Virtual patient educational programme to teach counselling to clinical pharmacists : development and proof of concept
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted..
Pharmacist-patient counselling can benefit patients and optimise care, but appropriate training is required. A virtual patient (VP) tool to teach pharmacists non-vitamin K oral anticoagulant counselling was developed; the VP may be used for continuing professional development. The objective was to develop and show proof of concept of the VP. A cyclic development approach was adopted whereby the client, developers and a steering group informed VP design, content and aesthetic. This included formal and informal evaluation; ethical approval was not required. The VP received varied feedback. Positive feedback concerned the technology and the high-standard of animations. Negative elements concerned international VP use and differences in practice, also technological comments, regarding VP delivery and usability on various electronic devices. The VP was reported to be 'valuable' and realistic with high-quality animations. The steering group commented on VP's clinical appropriateness, cultural relevance and usability. Areas highlighted for improvement were rectified during development, including the incorporation of printable feedback. European considerations concerned differences in culture and practice. The development process successfully developed the VP and the proof of the concept was demonstrated. This will inform future VP development; a large-scale VP evaluation is underway.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:5 |
|---|---|
| Enthalten in: |
BMJ simulation & technology enhanced learning - 5(2019), 3 vom: 23., Seite 167-169 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Richardson, Charlotte Lucy [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Counselling |
|---|
| Anmerkungen: |
Date Revised 07.05.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1136/bmjstel-2018-000352 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM340435186 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM340435186 | ||
| 003 | DE-627 | ||
| 005 | 20231226005227.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/bmjstel-2018-000352 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1134.xml |
| 035 | |a (DE-627)NLM340435186 | ||
| 035 | |a (NLM)35514947 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Richardson, Charlotte Lucy |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Virtual patient educational programme to teach counselling to clinical pharmacists |b development and proof of concept |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 07.05.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted. | ||
| 520 | |a Pharmacist-patient counselling can benefit patients and optimise care, but appropriate training is required. A virtual patient (VP) tool to teach pharmacists non-vitamin K oral anticoagulant counselling was developed; the VP may be used for continuing professional development. The objective was to develop and show proof of concept of the VP. A cyclic development approach was adopted whereby the client, developers and a steering group informed VP design, content and aesthetic. This included formal and informal evaluation; ethical approval was not required. The VP received varied feedback. Positive feedback concerned the technology and the high-standard of animations. Negative elements concerned international VP use and differences in practice, also technological comments, regarding VP delivery and usability on various electronic devices. The VP was reported to be 'valuable' and realistic with high-quality animations. The steering group commented on VP's clinical appropriateness, cultural relevance and usability. Areas highlighted for improvement were rectified during development, including the incorporation of printable feedback. European considerations concerned differences in culture and practice. The development process successfully developed the VP and the proof of the concept was demonstrated. This will inform future VP development; a large-scale VP evaluation is underway | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a counselling | |
| 650 | 4 | |a education | |
| 650 | 4 | |a pharmacist | |
| 650 | 4 | |a simulation | |
| 650 | 4 | |a virtual patient | |
| 700 | 1 | |a Chapman, Stephen |e verfasserin |4 aut | |
| 700 | 1 | |a White, Simon |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMJ simulation & technology enhanced learning |d 2015 |g 5(2019), 3 vom: 23., Seite 167-169 |w (DE-627)NLM280160216 |x 2056-6697 |7 nnns |
| 773 | 1 | 8 | |g volume:5 |g year:2019 |g number:3 |g day:23 |g pages:167-169 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/bmjstel-2018-000352 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 5 |j 2019 |e 3 |b 23 |h 167-169 | ||